Skip to content Skip to navigation
University of Warwick
  • Study
  • |
  • Research
  • |
  • Business
  • |
  • Alumni
  • |
  • News
  • |
  • About

University of Warwick
Publications service & WRAP

Highlight your research

  • WRAP
    • Home
    • Search WRAP
    • Browse by Warwick Author
    • Browse WRAP by Year
    • Browse WRAP by Subject
    • Browse WRAP by Department
    • Browse WRAP by Funder
    • Browse Theses by Department
  • Publications Service
    • Home
    • Search Publications Service
    • Browse by Warwick Author
    • Browse Publications service by Year
    • Browse Publications service by Subject
    • Browse Publications service by Department
    • Browse Publications service by Funder
  • Help & Advice
University of Warwick

The Library

  • Login
  • Admin

The identification of mitochondrial DNA variants in glioblastoma multiforme

Tools
- Tools
+ Tools

Yeung, Ka Yu, Dickinson, Adam, Donoghue, J. F., Polekhina, G., White, S. J., Grammatopoulos, Dimitris K., McKenzie, Matthew, Johnson, T. J. and St John, J. C. (2014) The identification of mitochondrial DNA variants in glioblastoma multiforme. Acta Neuropathologica Communications, 2 (1). 1. doi:10.1186/2051-5960-2-1 ISSN 2051-5960 .

[img]
Preview
PDF
WRAP-identification-mitochondrial-DNA-variants-glioblastoma-multiforme-Yeung-2013.pdf - Published Version - Requires a PDF viewer.
Available under License Creative Commons Attribution 2.0..

Download (1904Kb) | Preview
Official URL: http://dx.doi.org/10.1186/2051-5960-2-1

Request Changes to record.

Abstract

Background:
Mitochondrial DNA (mtDNA) encodes key proteins of the electron transfer chain (ETC), which produces ATP through oxidative phosphorylation (OXPHOS) and is essential for cells to perform specialised functions. Tumor-initiating cells use aerobic glycolysis, a combination of glycolysis and low levels of OXPHOS, to promote rapid cell proliferation and tumor growth. Glioblastoma multiforme (GBM) is an aggressively malignant brain tumor and mitochondria have been proposed to play a vital role in GBM tumorigenesis.
Results:
Using next generation sequencing and high resolution melt analysis, we identified a large number of mtDNA variants within coding and non-coding regions of GBM cell lines and predicted their disease-causing potential through in silico modeling. The frequency of variants was greatest in the D-loop and origin of light strand replication in non-coding regions. ND6 was the most susceptible coding gene to mutation whilst ND4 had the highest frequency of mutation. Both genes encode subunits of complex I of the ETC. These variants were not detected in unaffected brain samples and many have not been previously reported. Depletion of HSR-GBM1 cells to varying degrees of their mtDNA followed by transplantation into immunedeficient mice resulted in the repopulation of the same variants during tumorigenesis. Likewise, de novo variants identified in other GBM cell lines were also incorporated. Nevertheless, ND4 and ND6 were still the most affected genes. We confirmed the presence of these variants in high grade gliomas.
Conclusions:
These novel variants contribute to GBM by rendering the ETC. partially dysfunctional. This restricts metabolism to anaerobic glycolysis and promotes cell proliferation.

Item Type: Journal Article
Subjects: Q Science > QP Physiology
R Medicine > RC Internal medicine
Divisions: Faculty of Science, Engineering and Medicine > Medicine > Warwick Medical School > Biomedical Sciences > Translational & Experimental Medicine > Metabolic and Vascular Health (- until July 2016)
Faculty of Science, Engineering and Medicine > Medicine > Warwick Medical School
Library of Congress Subject Headings (LCSH): Mitochondrial DNA, Nucleotide sequence, Glioblastoma multiforme, Glioblastoma multiforme -- Treatment, Tumors -- Genetic aspects
Journal or Publication Title: Acta Neuropathologica Communications
Publisher: BioMed Central Ltd.
ISSN: 2051-5960
Official Date: 2 January 2014
Dates:
DateEvent
2 January 2014Published
7 December 2013Accepted
24 September 2013Submitted
Volume: 2
Number: 1
Article Number: 1
DOI: 10.1186/2051-5960-2-1
Status: Peer Reviewed
Publication Status: Published
Access rights to Published version: Open Access (Creative Commons)
Date of first compliant deposit: 24 January 2020
Date of first compliant Open Access: 24 January 2020
RIOXX Funder/Project Grant:
Project/Grant IDRIOXX Funder NameFunder ID
UNSPECIFIEDState Government of Victoriahttp://dx.doi.org/10.13039/501100004752
UNSPECIFIEDMonash Institute of Health Services Researchhttp://viaf.org/viaf/158503160
UNSPECIFIEDNational Health and Medical Research Councilhttp://dx.doi.org/10.13039/501100000925
UNSPECIFIEDJames and Vera Lawson TrustUNSPECIFIED
1012020National Health and Medical Research Councilhttp://dx.doi.org/10.13039/501100000925
UNSPECIFIEDFlack TrustUNSPECIFIED
UNSPECIFIED[MRC] Medical Research Councilhttp://dx.doi.org/10.13039/501100000265
Adapted As:

Request changes or add full text files to a record

Repository staff actions (login required)

View Item View Item

Downloads

Downloads per month over past year

View more statistics

twitter

Email us: wrap@warwick.ac.uk
Contact Details
About Us